Clinical trial
Clinical Outcomes of Intravenous Vitamin C Synergy With Tyrosine Kinase Inhibitor in Lung Adenocarcinoma Patients With Epidermal Growth Factor Receptor Mutations
NCT03799094 is registered in ClinicalTrials.gov with Clifford Hospital, Guangzhou, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Outcomes of Intravenous Vitamin C Synergy With Tyrosine Kinase Inhibitor in Lung Adenocarcinoma Patients With Epidermal Growth Factor Receptor Mutations
- Lead sponsor
- Clifford Hospital, Guangzhou, China
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- December 5, 2018
- Completion date
- December 31, 2022
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.